Find Research outputs

Search results

• A phase I study of idarubicin dose escalation with amifostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes

  Garcia-Manero, G., Faderl, S., Giles, F., Thomas, D., Cortes, J., O'Brien, S., Davis, J., Kantarjian, H. M. & Estey, E., Jan 1 2002, In: Haematologica. 87, 8, p. 804-807 4 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

  Borthakur, G., Dombret, H., Schafhausen, P., Brummendorf, T. H., Boisse, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., Kantarjian, H. & Cortes, J. E., Jul 6 2015, In: Haematologica. 100, 7, p. 898-904 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  42 Scopus citations

• A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

  Fenton, R. G., Steis, R. G., Madara, K., Zea, A. H., Ochoa, A. C., Janik, J. E., Smith, J. W., Gause, B. L., Sharfman, W. H., Urba, W. J., Hanna, M. G., DeJager, R. L., Coyne, M. X., Crouch, R. D., Gray, P., Beveridge, J., Creekmore, S. P., Holmlund, J., Curti, B. D., Sznol, M., & 1 othersLongo, D. L., 1996, In: Journal of Immunotherapy. 19, 5, p. 364-374 11 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms

  Assi, R., Kantarjian, H. M., Garcia-Manero, G., Cortes, J. E., Pemmaraju, N., Wang, X., Nogueras-Gonzalez, G., Jabbour, E., Bose, P., Kadia, T., Dinardo, C. D., Patel, K., Bueso-Ramos, C., Zhou, L., Pierce, S., Gergis, R., Tuttle, C., Borthakur, G., Estrov, Z., Luthra, R., & 3 othersHidalgo-Lopez, J., Verstovsek, S. & Daver, N., Feb 2018, In: American Journal of Hematology. 93, 2, p. 277-285 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  40 Scopus citations

• A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

  Kallab, A. M., Nalamolu, Y., Dainer, P. M. & Jillella, A. P., Jun 2005, In: Medical Oncology. 22, 2, p. 145-151 7 p.

  Research output: Contribution to journal › Article › peer-review
  6 Scopus citations

• A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

  Bertino, E. M., Bekaii-Saab, T., Fernandez, S., Diasio, R. B., Karim, N. A., Otterson, G. A. & Villalona-Calero, M. A., Jan 2013, In: Lung Cancer. 79, 1, p. 27-32 6 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract

  Barrett, J. T., Orofiamma, B., Khandekar, J. D., Carbone, P. P., Comis, R. L. & Davis, T. E., Dec 15 1989, In: Cancer. 64, 12, p. 2445-2447 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities

  Chen, Y., Kantarjian, H., Estrov, Z., Faderl, S., Ravandi, F., Rey, K., Cortes, J. & Borthakur, G., Oct 2012, In: Clinical Lymphoma, Myeloma and Leukemia. 12, 5, p. 341-344 4 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

  Lilenbaum, R., Samuels, M., Wang, X., Kong, F. M., Jänne, P. A., Masters, G., Katragadda, S., Hodgson, L., Bogart, J., Bradley, J. & Vokes, E., Jan 1 2015, In: Journal of Thoracic Oncology. 10, 1, p. 143-147 5 p.

  Research output: Contribution to journal › Article › peer-review
  38 Scopus citations

• A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

  Daver, N., Kantarjian, H., Ravandi, F., Estey, E., Wang, X., Garcia-Manero, G., Jabbour, E., Konopleva, M., O'Brien, S., Verstovsek, S., Kadia, T., Dinardo, C., Pierce, S., Huang, X., Pemmaraju, N., Diaz-Pines-Mateo, M., Cortes, J. & Borthakur, G., Feb 1 2016, In: Leukemia. 30, 2, p. 268-273 6 p.

  Research output: Contribution to journal › Article › peer-review
  54 Scopus citations

• A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

  Kantarjian, H. M., Lioure, B., Kim, S. K., Atallah, E., Leguay, T., Kelly, K., Marolleau, J. P., Escoffre-Barbe, M., Thomas, X. G., Cortes, J., Jabbour, E., O'Brien, S., Bories, P., Oprea, C., Hatteville, L. & Dombret, H., Mar 1 2016, In: Clinical Lymphoma, Myeloma and Leukemia. 16, 3, p. 139-145 7 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

  Tsai, H. J., Jiang, S. S., Hung, W. C., Borthakur, G., Lin, S. F., Pemmaraju, N., Jabbour, E., Bomalaski, J. S., Chen, Y. P., Hsiao, H. H., Wang, M. C., Kuo, C. Y., Chang, H., Yeh, S. P., Cortes, J., Chen, L. T. & Chen, T. Y., Dec 1 2017, In: Scientific reports. 7, 1, 11253.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  40 Scopus citations

• A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis

  Quintás-Cardama, A., Tong, W., Kantarjian, H., Thomas, D., Ravandi, F., Kornblau, S., Manshouri, T., Cortes, J. E., Garcia-Manero, G. & Verstovsek, S., May 2008, In: Leukemia. 22, 5, p. 965-970 6 p.

  Research output: Contribution to journal › Article › peer-review
  101 Scopus citations

• A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome

  Daver, N., Vega-Ruiz, A., Kantarjian, H. M., Estrov, Z., Ferrajoli, A., Kornblau, S., Verstovsek, S., Garcia-Manero, G. & Cortes, J. E., Sep 2013, In: European Journal of Cancer Care. 22, 5, p. 605-611 7 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL

  Jain, N., Balakrishnan, K., Ferrajoli, A., O'Brien, S. M., Burger, J. A., Kadia, T. M., Cortes, J. E., Ayres, M. L., Tambaro, F. P., Keating, M. J., Gandhi, V. & Wierda, W. G., 2017, In: Oncotarget. 8, 13, p. 22104-22112 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  5 Scopus citations

• A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology

  Miller, D. S., Blessing, J. A., Drake, R. D., Higgins, R., McMeekin, D. S., Puneky, L. V. & Krasner, C. N., Dec 2009, In: Gynecologic Oncology. 115, 3, p. 443-446 4 p.

  Research output: Contribution to journal › Article › peer-review
  31 Scopus citations

• A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

  Leslie, K. K., Sill, M. W., Fischer, E., Darcy, K. M., Mannel, R. S., Tewari, K. S., Hanjani, P., Wilken, J. A., Baron, A. T., Godwin, A. K., Schilder, R. J., Singh, M. & Maihle, N. J., Jun 2013, In: Gynecologic Oncology. 129, 3, p. 486-494 9 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study

  Chan, J. K., Deng, W., Higgins, R. V., Tewari, K. S., Bonebrake, A. J., Hicks, M., Gaillard, S., Ramirez, P. T., Chafe, W., Monk, B. J. & Aghajanian, C., Sep 2017, In: Gynecologic Oncology. 146, 3, p. 554-559 6 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A phase II clinical trial of a natural formulation containing tea catechins for xerostomia

  De Rossi, S. S., Thoppay, J., Dickinson, D. P., Looney, S., Stuart, M., Ogbureke, K. U. E. & Hsu, S., Oct 1 2014, In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 118, 4, p. 447-454.e3

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy

  Windisch, P., Stavropoulos, A., Molnár, B., Szendröi-Kiss, D., Szilágyi, E., Rosta, P., Horváth, A., Capsius, B., Wikesjö, U. M. E. & Sculean, A., Aug 2012, In: Clinical oral investigations. 16, 4, p. 1181-1189 9 p.

  Research output: Contribution to journal › Article › peer-review
  19 Scopus citations

• A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration

  Stavropoulos, A., Windisch, P., Gera, I., Capsius, B., Sculean, A. & Wikesjö, U. M. E., Nov 1 2011, In: Journal of Clinical Periodontology. 38, 11, p. 1044-1054 11 p.

  Research output: Contribution to journal › Article › peer-review
  44 Scopus citations

• A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction

  Hellstrom, W. J. G., Freier, M. T., Serefoglu, E. C., Lewis, R. W., Didonato, K. & Peterson, C. A., Jan 2013, In: BJU International. 111, 1, p. 137-147 11 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

  Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In: Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  38 Scopus citations

• A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2

  Holmlund, J. T., Kopp, W. C., Wiltrout, R. H., Longo, D. L., Urba, W. J., Janik, J. E., Sznol, M., Conlon, K. C., Fenton, R. G., Hornung, R., Madara, K., Shields, M. A., Smith, J. W., Sharfman, W., Steis, R. G., Ewel, C., Malspeis, L. & Creekmore, S. P., Jan 18 1995, In: Journal of the National Cancer Institute. 87, 2, p. 134-136 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  7 Scopus citations

• A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

  Wise-Draper, T. M., Moorthy, G., Salkeni, M. A., Karim, N. A., Thomas, H. E., Mercer, C. A., Beg, M. S., O’Gara, S., Olowokure, O., Fathallah, H., Kozma, S. C., Thomas, G., Rixe, O., Desai, P. & Morris, J. C., Jun 1 2017, In: Targeted Oncology. 12, 3, p. 323-332 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  61 Scopus citations

• A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

  Stock, W., Undevia, S. D., Bivins, C., Ravandi, F., Odenike, O., Faderl, S., Rich, E., Borthakur, G., Godley, L., Verstovsek, S., Artz, A., Wierda, W., Larson, R. A., Zhang, Y., Cortes, J., Ratain, M. J. & Giles, F. J., Aug 2008, In: Investigational New Drugs. 26, 4, p. 331-338 8 p.

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A Phase I and Pharmacokinetic Study of VNP40101M, a Novel Sulfonylhydrazine Alkylating Agent, in Patients with Refractory Leukemia

  Giles, F. J., Thomas, D., Garcia-Manero, G., Faderl, S., Cortes, J., Verstovsek, S., Ferrajoli, A., Jeha, S., Beran, M., Koller, C., Andreeff, M., Cahill, A., Clairmont, C., Sznol, M. & Kantarjian, H., May 1 2004, In: Clinical Cancer Research. 10, 9, p. 2908-2917 10 p.

  Research output: Contribution to journal › Article › peer-review
  47 Scopus citations

• A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

  Foran, J., Ravandi, F., Wierda, W., Garcia-Manero, G., Verstovsek, S., Kadia, T., Burger, J., Yule, M., Langford, G., Lyons, J., Ayrton, J., Lock, V., Borthakur, G., Cortes, J. & Kantarjian, H., Jun 2014, In: Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. 223-230 8 p.

  Research output: Contribution to journal › Article › peer-review
  30 Scopus citations

• A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia

  Daver, N., Boumber, Y., Kantarjian, H., Ravandi, F., Cortes, J., Rytting, M. E., Kawedia, J. D., Basnett, J., Culotta, K. S., Zeng, Z., Lu, H., Richie, M. A., Garris, R., Xiao, L., Liu, W., Baggerly, K. A., Jabbour, E., O'Brien, S., Burger, J., Bendall, L. J., & 2 othersThomas, D. & Konopleva, M., Jun 15 2015, In: Clinical Cancer Research. 21, 12, p. 2704-2714 11 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia

  Pemmaraju, N., Kantarjian, H., Kadia, T., Cortes, J., Borthakur, G., Newberry, K., Garcia-Manero, G., Ravandi, F., Jabbour, E., Dellasala, S., Pierce, S. & Verstovsek, S., Mar 1 2015, In: Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 171-176 6 p.

  Research output: Contribution to journal › Article › peer-review
  58 Scopus citations

• A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

  Swaminathan, M., Kantarjian, H. M., Levis, M., Guerra, V., Borthakur, G., Alvarado, Y., DiNardo, C. D., Kadia, T., Garcia-Manero, G., Ohanian, M., Daver, N., Konopleva, M., Pemmaraju, N., Ferrajol, A., Andreeff, M., Jain, N., Estrov, Z., Jabbour, E. J., Wierda, W. G., Pierce, S., & 4 othersPinsoy, M. R., Xiao, L., Ravandi, F. & Cortes, J. E., Aug 2021, In: Haematologica. 106, 8, p. 2121-2130 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  14 Scopus citations

• A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia

  Short, N. J., Kantarjian, H., Ravandi, F., Huang, X., Xiao, L., Garcia-Manero, G., Plunkett, W., Gandhi, V., Sasaki, K., Pemmaraju, N., Daver, N. G., Borthakur, G., Jain, N., Konopleva, M., Estrov, Z., Kadia, T. M., Wierda, W. G., DiNardo, C. D., Brandt, M., O’Brien, S. M., & 2 othersCortes, J. E. & Jabbour, E., Jul 19 2018, In: Leukemia and Lymphoma. 59, 4, p. 813-820 8 p.

  Research output: Contribution to journal › Article › peer-review
  12 Scopus citations

• A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

  Verstovsek, S., Hoffman, R., Mascarenhas, J., Soria, J. C., Bahleda, R., McCoon, P., Tang, W., Cortes, J., Kantarjian, H. & Ribrag, V., Feb 1 2015, In: Leukemia Research. 39, 2, p. 157-163 7 p.

  Research output: Contribution to journal › Article › peer-review
  24 Scopus citations

• A phase 3 trial of L-Glutamine in sickle cell disease

  Kumar Guddati, A. & Vamsi Kota, K., Nov 8 2018, In: New England Journal of Medicine. 379, 19, p. 1879 1 p.

  Research output: Contribution to journal › Letter › peer-review
  13 Scopus citations

• A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

  Réa, D., Mauro, M. J., Boquimpani, C., Minami, Y., Lomaia, E., Voloshin, S., Turkina, A., Kim, D. W., Apperley, J. F., Abdo, A., Fogliatto, L. M., Kim, D. D. H., le Coutre, P., Saussele, S., Annunziata, M., Hughes, T. P., Chaudhri, N., Sasaki, K., Chee, L., García-Gutiérrez, V., & 6 othersCortes, J. E., Aimone, P., Allepuz, A., Quenet, S., Bédoucha, V. & Hochhaus, A., Nov 25 2021, In: Blood. 138, 21, p. 2031-2041 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  31 Scopus citations

• A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

  Cortes, J. E., Kim, D. W., Pinilla-Ibarz, J., Le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., DiPersio, J., DeAngelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., Rivera, V. M., & 10 othersClackson, T., Turner, C. D., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T., Goldman, J. M., Shah, N. P. & Kantarjian, H., 2013, In: New England Journal of Medicine. 369, 19, p. 1783-1796 14 p.

  Research output: Contribution to journal › Article › peer-review
  760 Scopus citations

• A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

  Masarova, L., Verstovsek, S., Hidalgo-Lopez, J. E., Pemmaraju, N., Bose, P., Estrov, Z., Jabbour, E. J., Ravandi-Kashani, F., Takahashi, K., Cortes, J. E., Ning, J., Ohanian, M., Alvarado, Y., Zhou, L., Pierce, S., Gergis, R., Patel, K. P., Luthra, R., Kadia, T. M., DiNardo, C. D., & 6 othersBorthakur, G., Bhalla, K., Garcia-Manero, G., Bueso-Ramos, C. E., Kantarjian, H. M. & Daver, N., Oct 18 2018, In: Blood. 132, 16, p. 1664-1674 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  44 Scopus citations

• A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer

  Stein, S. M., Tiersten, A., Hochster, H. S., Blank, S. V., Pothuri, B., Curtin, J., Shapira, I., Levinson, B., Ivy, P., Joseph, B., Guddati, A. K. & Muggia, F., 2013, In: International Journal of Gynecological Cancer. 23, 9, p. 1577-1582 6 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

  Seymour, J. F., Kim, D. W., Rubin, E., Haregewoin, A., Clark, J., Watson, P., Hughes, T., Dufva, I., Jimenez, J. L., Mahon, F. X., Rousselot, P., Cortes, J., Martinelli, G., Papayannidis, C., Nagler, A. & Giles, F. J., Aug 2014, In: Blood Cancer Journal. 4, 8, e238.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  53 Scopus citations

• A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction

  Tita, C., Gilbert, E. M., Van Bakel, A. B., Grzybowski, J., Haas, G. J., Jarrah, M., Dunlap, S. H., Gottlieb, S. S., Klapholz, M., Patel, P. C., Pfister, R., Seidler, T., Shah, K. B., Zieliński, T., Venuti, R. P., Cowart, D., Foo, S. Y., Vishnevsky, A. & Mitrovic, V., Oct 2017, In: European Journal of Heart Failure. 19, 10, p. 1321-1332 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  38 Scopus citations

• A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. H., Huh, W., Behbakht, K., Ball, G., Cuasay, L., Würtz, S. O., Brunner, N. & Gold, M. A., Oct 2008, In: Gynecologic Oncology. 111, 1, p. 89-94 6 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. & Gold, M., Jul 2009, In: Gynecologic Oncology. 114, 1, p. 137 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

  Monk, B. J., Brady, M. F., Aghajanian, C., Lankes, H. A., Rizack, T., Leach, J., Fowler, J. M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E. M., Anderson, K. S., Gottardo, R., Bryan, J. K., Newkirk, M., Manjarrez, K. L., & 3 othersMannel, R. S., Hershberg, R. M. & Coukos, G., May 1 2017, In: Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 996-1004 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  43 Scopus citations

• A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III

  Hillier, S. L., Ferrieri, P., Edwards, M. S., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H. & Baker, C. J., Jun 2019, In: Clinical Infectious Diseases. 68, 12, p. 2079-2086 8 p., ciy838.

  Research output: Contribution to journal › Article › peer-review
  19 Scopus citations

• A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

  Vazquez, J. A., Schranz, J. A., Clark, K., Goldstein, B. P., Reboli, A. & Fichtenbaum, C., Jul 1 2008, In: Journal of Acquired Immune Deficiency Syndromes. 48, 3, p. 304-309 6 p.

  Research output: Contribution to journal › Article › peer-review
  35 Scopus citations

• A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

  Fathi, A. T., Erba, H. P., Lancet, J. E., Stein, E. M., Ravandi, F., Faderl, S., Walter, R. B., Advani, A. S., DeAngelo, D. J., Kovacsovics, T. J., Jillella, A., Bixby, D., Levy, M. Y., O’Meara, M. M., Ho, P. A., Voellinger, J. & Stein, A. S., Sep 13 2018, In: Blood. 132, 11, p. 1125-1133 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  40 Scopus citations

• A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

  Stein, E. M., Walter, R. B., Erba, H. P., Fathi, A. T., Advani, A. S., Lancet, J. E., Ravandi, F., Kovacsovics, T., DeAngelo, D. J., Bixby, D., Faderl, S., Jillella, A. P., Ho, P. A., O'Meara, M. M., Zhao, B., Biddle-Snead, C. & Stein, A. S., Jan 25 2018, In: Blood. 131, 4, p. 387-396 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  92 Scopus citations

• A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

  Colombo, R. E., Fiorentino, C., Dodd, L. E., Hunsberger, S., Haney, C., Barrett, K., Nabha, L., Davey, R. T. & Olivier, K. N., Feb 1 2016, In: BMC Infectious Diseases. 16, 1, 54.

  Research output: Contribution to journal › Article › peer-review
  15 Scopus citations

• A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

  Ghamande, S., Lin, C. C., Cho, D. C., Shapiro, G. I., Kwak, E. L., Silverman, M. H., Tseng, Y., Kuo, M. W., Mach, W. B., Hsu, S. C., Coleman, T., Yang, J. C. H., Cheng, A. L., Ghalib, M. H., Chuadhary, I. & Goel, S., Jun 2014, In: Investigational New Drugs. 32, 3, p. 445-451 7 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤30% blasts

  Garcia-Manero, G., Sekeres, M. A., Egyed, M., Breccia, M., Graux, C., Cavenagh, J. D., Salman, H., Illes, A., Fenaux, P., Deangelo, D. J., Stauder, R., Yee, K., Zhu, N., Lee, J. H., Valcarcel, D., Macwhannell, A., Borbenyi, Z., Gazi, L., Acharyya, S., Ide, S., & 2 othersMarker, M. & Ottmann, O. G., 2017, In: Leukemia. 31, 12, p. 2799-2806 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  45 Scopus citations